Secondary Respiratory Infections in the Context of Acute and Chronic Pulmonary Diseases

161.5K

views

70

authors

13

articles

Editorial

27 November 2019

Editorial: Secondary Respiratory Infections in the Context of Acute and Chronic Pulmonary Diseases

François Trottein

and

John F. Alcorn

2,920 views

2 citations

Editors

2

François TROTTEIN

Institut Pasteur de Lille

Children's Hospital of Pittsburgh, School of Medicine, University of Pittsburgh

Impact

About

Secondary respiratory bacterial infections arising from pulmonary insults remain a major clinical issue today. Acute or chronic, sterile or infection-driven, pulmonary inflammation predispose to secondary infections. Secondary bacterial infections often result in lethal synergy with primary infection in the lung or, in the case of sepsis, throughout the body. Different mechanisms are implicated in this enhanced susceptibility including disruption of the lung barrier integrity and impaired host defenses. Today’s treatments of secondary bacterial infections are still not effective enough and antibiotic resistance is a major issue. Hence, there is an urgent need for novel therapies.

The goal of this Research Topic is to highlight our current understanding of the mechanisms leading to secondary bacterial infections in the context of pulmonary injury and to update ongoing and future strategies, including immunotherapy, to overcome altered barrier functions and/or immunosuppression to improve patient outcome. We welcome the submission of Review, Mini-Review and Original Research articles covering, but not limited to, the following topics:

1. Consequences of respiratory viral infections on secondary bacterial infections.
2. Consequences of sepsis on secondary bacterial infections.
3. Consequences of chronic pulmonary illnesses on respiratory bacterial super-infection.

Secondary respiratory bacterial infections arising from pulmonary insults remain a major clinical issue today. Acute or chronic, sterile or infection-driven, pulmonary inflammation predispose to secondary infections. Secondary bacterial infections often result in lethal synergy with primary infection in the lung or, in the case of sepsis, throughout the body. Different mechanisms are implicated in this enhanced susceptibility including disruption of the lung barrier integrity and impaired host defenses. Today’s treatments of secondary bacterial infections are still not effective enough and antibiotic resistance is a major issue. Hence, there is an urgent need for novel therapies.

The goal of this Research Topic is to highlight our current understanding of the mechanisms leading to secondary bacterial infections in the context of pulmonary injury and to update ongoing and future strategies, including immunotherapy, to overcome altered barrier functions and/or immunosuppression to improve patient outcome. We welcome the submission of Review, Mini-Review and Original Research articles covering, but not limited to, the following topics:

1. Consequences of respiratory viral infections on secondary bacterial infections.
2. Consequences of sepsis on secondary bacterial infections.
3. Consequences of chronic pulmonary illnesses on respiratory bacterial super-infection.

Download ebook

Share

Editors

François TROTTEIN

Institut Pasteur de Lille

Children's Hospital of Pittsburgh, School of Medicine, University of Pittsburgh

Impact

161,491 Total views

114,676 Article views

41,552 Article downloads

5,263 Topic views

Published In

Journal Thumbnail

Frontiers in Immunology

T Cell Biology, Microbial Immunology

Journal Thumbnail

Frontiers in Microbiology

Microbial Immunology

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic